Patterns of relapse in the Lung ART trial of postoperative radiotherapy for resected NSCLC

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Sep 17 / Springer Healthcare

Patterns of relapse in the Lung ART trial of postoperative radiotherapy for resected NSCLC

Oncology Lung Cancer ESMO-2021

Description

Independent commentator Stephen Liu discusses how the longer follow-up and data on patterns of relapse bolster the primary result of the Lung ART trial that ruled out the use of postoperative radiotherapy for patients with completely resected non-small-cell lung cancer and mediastinal N2 involvement.

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.